BLOG

Woburn-based biotech company seeing promising results in COVID-19 antibody treatment

A Woburn-based biotech company says it’s seeing early success with COVID-19 antibody treatments. Scientists at Abpro have been studying antibodies for a decade but the CEO says this research hits differently.